Abstract:Background:The majority of patients with colorectal cancer (CRC) have increased levels of soluble cancer-associated biomarkers at diagnosis of primary disease.Subjects with clean colorectum at colonoscopy may however, also have increased levels of such biomarkers.The aim of the present study was to evaluate a possible association between increased levels of soluble TIMP-1, CEA, CA19-9 and YKL-40 in subjects offered colorectal endoscopy without findings of neoplastic bowel lesions and subsequent long-term risk of developing a primary malignant disease.Methods: During 2004/05 4,509 subjects were included in a multicenter study with collection of blood samples before sigmoido-and/or colonoscopy due to symptoms of CRC.The aim was to evaluate a possible relation between certain biomarkers and subsequent findings at endoscopy.A subgroup of 1,025 subjects had findings of diverticula and was chosen as research group, because the median age was similar to the subjects diagnosed with colorectal neoplasia.The levels of TIMP-1, CEA and CA19-9 were determined in EDTA plasma at an automatic analysis platform "Architect®" at Abbotts Center of Excellence, Amsterdam and YKL-40 was determined on a validated commercially available ELISA platform (Quidell, USA) at Herlev Hospital.With cut-point 12.31.2012 the subjects, who have developed a primary malignant disease, except skin cancer, were identified and a relation between the biomarker levels at endoscopy and long-term risk of developing malignancy was calculated.On the basis of calculated normal levels, the relation with the biomarkers was separated into three groups: 0 = none of the four increased; 1 = one of the four increased; 2 = two or more of the four increased.In addition, the time from endoscopy to development of malignancy within the first five years was included; the model also includes an analysis of competing risk of dead before development of malignancy.Results: In total, 152 of the 1,025 subjects with diverticula developed a primary malignant disease within the observation period.Univariate analyses of the biomarker levels in the three predefined groups showed that TIMP-1 (p=0.0004),CEA (p=0.009) and CA19-9 (p=0.028) were significantly associated with development of malignancy.In a subsequent multivariate analysis including the three biomarkers showed that increased levels were associated with development of subsequent malignancy (p=0.0014).The cumulated risk of developing a primary malignant disease within the first five years was: group 0: 0.075 (0.055-0.099); group 1: 0.088 (0.059-0.126); group 2: 0.167 (0.120-0.221).Conclusion: Increased levels of the soluble biomarkers plasma TIMP-1, CEA and CA19-9 at endoscopy with findings of diverticula are associated with subsequent risk of developing a primary malignant disease.

Preoperative Serum TMAO Level is a New Prognostic Marker for Colorectal Cancer.

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke.

Associations of serum trimethylamine N‐oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort

Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer

Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke

Dmso_a_339698 69..78

Effect of TMAO on the incidence and prognosis of cerebral infarction: a systematic review and meta-analysis

Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality

Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study

Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine

Elevated trimethylamine N-oxide related to ischemic brain lesions after carotid artery stenting.

Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)

TMAO as a Novel Predictor of Major Adverse Vascular Events and Recurrence in Patients with Large Artery Atherosclerotic Ischemic Stroke

The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus

872 Mir-650: A Potential Prognostic Biomarker and Therapeutic Target in Non-Metastasis Colorectal Carcinoma

Urinary metabonomic study on colorectal cancer.

Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease

Emerging role of trimethylamine-N-oxide (TMAO) in colorectal cancer

Trimethylamine N-oxide promotes the proliferation and migration of hepatocellular carcinoma cell through the MAPK pathway

Circulating Trimethylamine-N-Oxide Is Elevated in Liver Transplant Recipients

The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases